Plasma Therapy Market
Plasma Therapy Market Size, Share & Trends Analysis Report by Type (Leukocyte-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (PRF), Leucocyte-Rich PRP, and Pure PRP), by Application (Orthopedics, Dermatology, Dental, and Others), and by End-User (Hospitals & Clinics and Research Institutions) Forecast Period, (2026-2035)
Industry Overview
Plasma therapy market valued at $1,103.5 million in 2025 and is projected to reach $2,664.9 million by 2035, growing at a CAGR of 9.3% during the forecast period (2026-2035). The global plasma therapy market is progressing steadily as healthcare systems and biopharmaceutical companies intensify their focus on advanced biologics derived from human plasma. Growth is being driven by the rising prevalence of chronic and rare diseases, including immunodeficiency disorders, neurological conditions, and hematological abnormalities, which require plasma-derived therapies for effective management. Increasing adoption of fractionation technologies, improved plasma collection infrastructure, and expanding clinical applications of immunoglobulins and albumin are further strengthening market expansion. Additionally, the growing emphasis on patient-centric treatment approaches and evidence-based therapeutics is reinforcing the role of plasma therapies in modern healthcare systems.
Market Dynamics
Rising Demand for Plasma-Derived Therapies in Chronic and Rare Diseases
The increasing global burden of chronic and rare diseases is significantly driving the demand for plasma-derived therapies such as immunoglobulins, coagulation factors, and albumin. Healthcare providers are increasingly relying on these therapies for the treatment of conditions such as primary immunodeficiency disorders, hemophilia, and autoimmune diseases. Advancements in diagnostic capabilities are also enabling earlier detection, thereby expanding the patient pool requiring long-term plasma-based treatments. As awareness regarding the clinical benefits of plasma therapies grows, pharmaceutical companies are scaling up production capacities and strengthening supply chains. This sustained demand is emerging as a key factor supporting overall market growth.
Expansion of Plasma Collection and Fractionation Infrastructure
The plasma therapy market is witnessing increased investment in plasma collection centers and fractionation facilities to address the rising global demand. Companies are focusing on expanding donor networks, improving collection efficiency, and ensuring high-quality plasma supply through advanced screening and processing technologies. Technological improvements in fractionation processes are enhancing yield, purity, and safety of plasma-derived products, enabling manufacturers to optimize production. Additionally, regulatory frameworks emphasizing quality assurance and traceability are encouraging the adoption of standardized processing systems. This ongoing expansion of infrastructure is playing a crucial role in strengthening market scalability and reliability.
Growing Integration of Advanced Bioprocessing and Manufacturing Technologies
Biopharmaceutical companies are increasingly adopting advanced bioprocessing techniques and automation in plasma fractionation and product development. Innovations in purification methods, viral inactivation processes, and cold chain logistics are improving product safety and efficacy. Automation and digital monitoring systems are helping streamline production workflows, reduce operational errors, and enhance batch consistency. Furthermore, the integration of data-driven manufacturing approaches is enabling better forecasting and inventory management. These advancements are supporting efficient large-scale production while maintaining stringent regulatory compliance, thereby contributing to market growth.
Market Segmentation
- Based on the type, the market is segmented into leukocyte-rich fibrin (L-PRF), pure platelet-rich fibrin (PRF), leucocyte-rich PRP, and pure PRP.
- based on the application, the market is segmented into orthopedics, dermatology, dental, and others.
- based on the end-user, the market is segmented into hospitals & clinics and research institutions.
Leukocyte-Rich PRP Segment to Dominate the Market with the Largest Share
In the global plasma therapy market, the leukocyte-rich PRP segment is expected to account for the largest market share, driven by its widespread clinical adoption and proven effectiveness in accelerating tissue repair and healing. This type of plasma therapy is extensively utilized in various medical fields due to its ability to enhance immune response and promote regenerative processes. Increasing demand for minimally invasive treatments, coupled with rising awareness about regenerative medicine, is further supporting segment growth. Additionally, advancements in preparation techniques and improved standardization of platelet-rich plasma therapies are enhancing treatment outcomes. These factors collectively strengthen the dominance of the leukocyte-rich PRP segment in the overall market.
Orthopedics Segment: A Key Contributor to Market Growth
The orthopedics segment plays a significant role in driving growth within the plasma therapy market, owing to the increasing prevalence of musculoskeletal disorders and sports-related injuries. Plasma-based therapies are widely used in orthopedic treatments to promote faster recovery, reduce inflammation, and improve joint function. The growing preference for non-surgical and regenerative treatment options among patients is further accelerating adoption in this segment. In addition, continuous research and clinical advancements are expanding the application of plasma therapies in treating conditions such as osteoarthritis and tendon injuries. Together, these factors position orthopedics as a major contributor to the overall expansion of the plasma therapy market.
Regional Outlook
The global plasma therapy market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Europe Strengthens Position Through Structured Plasma Collection Systems
Europe is witnessing steady growth in the plasma therapy market due to well-established healthcare infrastructure and organized plasma collection systems. Government-supported healthcare programs and strong regulatory oversight are facilitating the adoption of plasma-derived therapies across the region. Increasing collaboration between public health institutions and private biopharmaceutical companies is enhancing plasma availability and improving treatment accessibility. Additionally, the region’s focus on maintaining high standards for product safety and donor management is encouraging continued investment in advanced processing technologies. This structured ecosystem is supporting consistent market expansion across European countries.
North America Region Dominates the Market with Major Share
North America holds a dominant position in the global plasma therapy market, supported by a robust network of plasma collection centers and advanced biopharmaceutical manufacturing capabilities. The region benefits from high awareness levels, strong reimbursement frameworks, and widespread adoption of plasma-derived therapies for a range of clinical indications. Continuous investment in research and development is enabling the introduction of innovative therapies and improved formulations. Furthermore, favorable regulatory policies and the presence of leading market players are strengthening production capacity and distribution efficiency. These factors collectively reinforce North America’s leading share in the global market.
Market Players Outlook
The major companies operating in the global plasma therapy market includes Exactech, Inc., Johnson & Johnson Services, Inc., Stryker Corporation, Terumo Corporation, Zimmer Biomet Holdings, Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In July 2025, Grifols S.A. expanded its plasma collection network in North America by opening new donor centers aimed at increasing raw material supply for immunoglobulin production.
- In March 2025, CSL Limited announced advancements in its plasma fractionation technology designed to enhance yield efficiency and improve scalability of plasma-derived therapies.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global plasma therapy Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Plasma Therapy Market Sales Analysis – Type | Application | End-User ($ Million)
- Plasma Therapy Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Plasma Therapy Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Plasma Therapy Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Plasma Therapy Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Plasma Therapy Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Plasma Therapy Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Plasma Therapy Market Revenue and Share by Manufacturers
- Plasma Therapy Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Exactech, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson Services, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Stryker Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Terumo Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Zimmer Biomet Holdings, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Exactech, Inc.
- Key Company Analysis
- Global Plasma Therapy Market Sales Analysis by Type ($ Million)
- Leukocyte-Rich Fibrin (L-PRF)
- Pure Platelet-Rich Fibrin (PRF)
- Leucocyte-Rich PRP
- Pure PRP
- Global Plasma Therapy Market Sales Analysis by Application ($ Million)
- Orthopedics
- Dermatology
- Dental
- Others
- Global Plasma Therapy Market Sales Analysis by End-User ($ Million)
- Hospitals & Clinics
- Research Institutions
- Regional Analysis
- North American Plasma Therapy Market Sales Analysis – Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Plasma Therapy Market Sales Analysis – Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Plasma Therapy Market Sales Analysis – Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Plasma Therapy Market Sales Analysis – Type | Application | End-User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- AdiStem Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Apex Biologix
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Arthrex, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biocomposites Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Celling Biosciences, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cesca Therapeutics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- PRP USA LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- EmCyte Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Exactech, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Glofinn Oy
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Harvest Technologies Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ISTO Biologics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson Services, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Juventix Regenerative Medical LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nuo Therapeutics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Regen Lab SA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Stryker Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Terumo Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zimmer Biomet Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- AdiStem Ltd.
1. Global Plasma Therapy Market Research and Analysis by Type, 2025–2035 ($ Million)
2. Global Leukocyte-Rich Fibrin (L-PRF) Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Pure Platelet-Rich Fibrin (PRF) Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Leucocyte-Rich PRP Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Pure PRP Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Plasma Therapy Market Research and Analysis by Application, 2025–2035 ($ Million)
7. Global Orthopedics Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Dermatology Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Dental Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Others Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Plasma Therapy Market Research and Analysis by End-User, 2025–2035 ($ Million)
12. Global Plasma Therapy for Hospitals & Clinics Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Plasma Therapy for Research Institutions Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
15. North American Plasma Therapy Market Research and Analysis by Country, 2025–2035 ($ Million)
16. North American Plasma Therapy Market Research and Analysis by Type, 2025–2035 ($ Million)
17. North American Plasma Therapy Market Research and Analysis by Application, 2025–2035 ($ Million)
18. North American Plasma Therapy Market Research and Analysis by End-User, 2025–2035 ($ Million)
19. European Plasma Therapy Market Research and Analysis by Country, 2025–2035 ($ Million)
20. European Plasma Therapy Market Research and Analysis by Type, 2025–2035 ($ Million)
21. European Plasma Therapy Market Research and Analysis by Application, 2025–2035 ($ Million)
22. European Plasma Therapy Market Research and Analysis by End-User, 2025–2035 ($ Million)
23. Asia-Pacific Plasma Therapy Market Research and Analysis by Country, 2025–2035 ($ Million)
24. Asia-Pacific Plasma Therapy Market Research and Analysis by Type, 2025–2035 ($ Million)
25. Asia-Pacific Plasma Therapy Market Research and Analysis by Application, 2025–2035 ($ Million)
26. Asia-Pacific Plasma Therapy Market Research and Analysis by End-User, 2025–2035 ($ Million)
27. Rest of the World Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
28. Rest of the World Plasma Therapy Market Research and Analysis by Type, 2025–2035 ($ Million)
29. Rest of the World Plasma Therapy Market Research and Analysis by Application, 2025–2035 ($ Million)
30. Rest of the World Plasma Therapy Market Research and Analysis by End-User, 2025–2035 ($ Million)
1. Global Plasma Therapy Market Share by Type, 2025 Vs 2035 (%)
2. Global Leukocyte-Rich Fibrin (L-PRF) Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
3. Global Pure Platelet-Rich Fibrin (PRF) Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
4. Global Leucocyte-Rich PRP Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
5. Global Pure PRP Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
6. Global Plasma Therapy Market Research and Analysis by Application, 2025 Vs 2035 (%)
7. Global Orthopedics Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
8. Global Dermatology Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
9. Global Dental Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
10. Global Others Plasma Therapy Market Share by Region, 2025 Vs 2035 (%)
11. Global Plasma Therapy Market Research and Analysis by End-User, 2025 Vs 2035 (%)
12. Global Plasma Therapy for Hospitals & Clinics Market Share by Region, 2025 Vs 2035 (%)
13. Global Plasma Therapy for Research Institutions Market Share by Region, 2025 Vs 2035 (%)
14. Global Plasma Therapy Market Research and Analysis by Region, 2025–2035 ($ Million)
15. US Plasma Therapy Market Size, 2025–2035 ($ Million)
16. Canada Plasma Therapy Market Size, 2025–2035 ($ Million)
17. UK Plasma Therapy Market Size, 2025–2035 ($ Million)
18. France Plasma Therapy Market Size, 2025–2035 ($ Million)
19. Germany Plasma Therapy Market Size, 2025–2035 ($ Million)
20. Italy Plasma Therapy Market Size, 2025–2035 ($ Million)
21. Spain Plasma Therapy Market Size, 2025–2035 ($ Million)
22. Russia Plasma Therapy Market Size, 2025–2035 ($ Million)
23. Rest of Europe Plasma Therapy Market Size, 2025–2035 ($ Million)
24. India Plasma Therapy Market Size, 2025–2035 ($ Million)
25. China Plasma Therapy Market Size, 2025–2035 ($ Million)
26. Japan Plasma Therapy Market Size, 2025–2035 ($ Million)
27. South Korea Plasma Therapy Market Size, 2025–2035 ($ Million)
28. Australia and New Zealand Plasma Therapy Market Size, 2025–2035 ($ Million)
29. ASEAN Economies Plasma Therapy Market Size, 2025–2035 ($ Million)
30. Rest of Asia-Pacific Plasma Therapy Market Size, 2025–2035 ($ Million)
31. Latin America Plasma Therapy Market Size, 2025–2035 ($ Million)
32. Middle East and Africa Plasma Therapy Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
